In the lat­est chap­ter of Emer­gent saga, CEO Bob Kramer will ad­dress US House sub­com­mit­tee on plant woes

Emer­gent CEO Bob Kramer has had to ex­plain to in­vestors, the me­dia and the Amer­i­can pub­lic just what went wrong at his com­pa­ny’s Bal­ti­more plant that led to the mix­up of mil­lions of vac­cine dos­es in March. Next up is the US House of Rep­re­sen­ta­tives’ coro­n­avirus sub­com­mit­tee.

Kramer will meet with the sub­com­mit­tee May 19 to ex­plain how Emer­gent’s fail­ure to main­tain its man­u­fac­tur­ing fa­cil­i­ties, train its staff and com­ply with FDA stan­dards led to the de­struc­tion of 15 mil­lion dos­es of the J&J vac­cine, as well as dos­es of As­traZeneca’s vac­cine.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER